of the blood-brain barrier (BBB) is that of an absolute barrier prohibiting the entrv of bloodborne solu tes into the central nervous system (CNS > (W This concept was based primarily on the inability of a wide variety of dyes to stain the CNS which, however, were capable of staining most peripheral tissues (12). This concept became untenable when Rawson (33) and Tschirgi (45) demonstrated that blood-borne dyes were bound predominantly to plasma proteins, and it became apparent that the limited entry of dyes into the CNS actually represented restriction to the entry of dye-protein complexes. Recent electron microscopic findings have suggested that the specialized intermembranous fusions or "tight junctions" occurring between endothelial cells of cerebral blood vessels (10, 34) and the lack of appreciable pinocytotic activity (34) may represent the morphological basis of the BBB to plasma proteins and other large molecules. Enhanced penetration of plasma protein and other large molecules into brain may thus reflect an alteration in cerebrovascular permeability.
In the past a variety of techniques have been employed in attempt to induce increased passage of plasma proteins or other large molecules into the CNS. However, in many of these studies the techniques employed inflicted lesions which were traumatic and resulted in frank destruction of cerebral vasculature and parenchyma (8). It is questionable whether under these circumstances the increased penetration of plasma proteins into brain could be attributed to alteration of vascular permeability. Other studies, in which the use of traumatic lesions was avoided to induce increased passage of plasma proteins into the CNS, failed to indicate whether such alterations were transient or permanent.
Finally, in such studies few have dealt with the ultimate fate of plasma proteins with gained access to the CNS (21, 30) .
Increased penetration of plasma proteins into the CNS as a result of experimentally induced seizures has been reported by others (23, 29) to be a result of altered cerebrovascular permeability.
The object of the present investigation was to determine 1) whether prolonged seizures actually effected cerebrovascular permeability to circulating radioiodinated human serum albumin (HSA-I) and 2) the fate of plasma protein which gained access to brain.
METHODS

Operative and Convulsive Procedures
The procedures used in these experiments were essentially those reported by Lorenzo et al. (25, 26) . In brief, mongrel cats of either sex weighing 2.0-3.5 kg were partially paralyzed with gallamine triethiodide (4-8 mg/kg, ip). Operative procedures were performed under careful local analgesia produced with 1 % lidocaine containing epinephrine. After a tracheostomy the animal was completely paralyzed with an additional injection of gallamine-triethiodide (2 mg/kg, iv) and was then artificially respired at carefully controlled rates and volumes. Brain electrical activity (EEG) was monitored with scalp electrodes placed on the frontal bones, and electrodes placed in a second standard limb lead position were used to monitor cardiac activity (ECG). Arterial, venous, and cerebrospinal fluid pressures were monitored using pressure transducers.
Recordings were made on a Beckman type R Dynograph.
After all surgical procedures were completed the animals were allowed to remain undisturbed for 30 min.
The animals were divided into six groups: Group 1: pentylenetetrazol convulsed. 1251-or 13rI-labeled human serum albumin (HSA-lz51 and HSA 1311, respectively) was administered intravenously in a dose of 100-300 PC/kg. Ten minutes after the administration of the isotope a con- The onset of seizure activity was easily detected by the appearance of paroxysmal discharge in the EEG. When necessary, seizure activity was maintained with supplemental intravenous injections of PTZ. Animals were convulsed for periods of 5, 15, 30, and 60 min before being killed. Thirty seconds prior to the termination of the seizure period, 1,000 units of heparin sodium were administered intravenously immediately followed by a lethal dose of pentobarbital (60 mg/kg, iv). A midline thoracotomy was then performed, the pericardium was cut, and 5-10 ml of blood were drawn from the left ventricle. The upper trunk and head were cleared of their intravascular contents by perfusion with normal saline through an aortic cannula.
CSF, l-2 ml, was drawn from the cisterna magna. The brain was then removed, placed in a deep freezer, and kept at -20 C. In some animals liver, kidney, gastrocnemius or temporal muscle, and sciatic nerve were also sampled and frozen.
Animals in all subsequent groups were treated in a similar manner except where noted.
Group 2: animals convulsed withpentylenetetrasol and infused with norepinephrine. In the group I animals the arterial blood pressure rose abruptly with the onset of seizure act ivity. How& ever, with time the pressure gradually but steadily declined so that after 30 min of seizure activity the arterial blood pressure generally fell below the preseizure level. To avoid this decline, norepinephrine was infused intravenously at a rate of 0.004 mg/min.
In addition, a second group of animals was treated 10 min prior to PTZ administration with the anticholinergic agent methantheline bromide (4 mg/ kg, iP)-Group 3: animals convulsed with pentylenetetrasol and sacrzjlced at various time intervals after seizure arrest. Trimethadione (200-400 q/kg, > iv was administered to arrest the seizure activity 60 min after its onset. The animals were killed 5, 10, 15, and 30 min after arrest of seizure activity.
Group 4: animals convulsed with pentylenetetracol for 60 min but exposed to circulating HSA-lz51 for limited intervals. The effect of a limited time exposure to circulating HSA-1251 was investigated in animals convulsed for 60 min but to which the isotope was administered 30, 15, and 5 min prior to the time of sacrifice.
Group 5: nonconvulsed animals infused with norepinephrine. Norepinephrine was infused intravenously at a rate of 0.004 mg/min for a period of 60 min into nonconvulsed animals. Group 6: nonconvulsed animals. Animals were killed (as described in group 1) 15 and 70 min after the intravenous administration of HSA-1251.
Cerebral Blood Flow and Blood Volume
The indicator-fractionation technique of Sapirstein (36) was used to determine the regional blood flow to brain. Animals were anesthetized with ether, the trachea was cannulated, and an arteriovenous shunt was implanted between the femoral artery and vein using PE-60 Intramedic tubing. The overall length of the tubing was approximately 120 cm, and its volume was 0.55 ml. The most distal or loop end of the shunt was wrapped about a solid cylinder of plastic, 1.5 cm in length, 0.8 cm in diameter.
Proximal to this, the tube was passed through a lead cylinder 2 cm in length and I .5 cm in diameter. The tubing, plastic, and the lead cylinder were inserted into a glass test tube, 150 x 16 mm, and sealed with a rubber stopper notched on two sides to secure the tubing and contents. The test tube and its contents were then inserted into the well of a scintillation counter. In this manner it was possible by adjusting the length of the PE tubing wrapped about the plastic end piece to limit the amount of blood exposed to the NaI crystal of the scintillation counter. The volume of the exposed PE tubing was determined prior to the actual cannulation by filling the PE tubing with a standard solution of HSA-1251 and determining the number of counts registered. The tubing was then rinsed several times with heparinized saline to clear the radioactivity.
The contralateral femoral vein was also cannulated for the purpose of administering drugs and isotopes. The animal was then paralyzed with gallamine triethiodide (2.5 mg/kg, iv) and artificially respired at rates commensurate with the animals weight. In order to prevent clot formation in the shunt, heparin sodium (1,000 units, iv) was administered. One hour after the animal had been paralyzed a calibrated dose of HSA-1251 was administered intravenously and counts were obtained every second for the first minute and thereafter every minute for the next 9 min. The accumulated data allowed us to determine the cardiac output. In order to determine regional blood flow, a calibrated-dose of antipyrine-1311 was administered at 10 min. At various intervals after the administration of antipyrine the animal's head was cut off with a guillotine and allowed to fall directly into a freezing solution. The head was then removed from the solution in a -20" C cold room and cut into approximately l-cm-thick slices. The portion of brain contained within each slice was separated from the surrounding bony encasement with rongeurs. Thinner slices, l-2 mm thick, were then cut from these sections. Finally, eight anatomical brain areas were dissected frum these slices and assayed for 1311 and lz51 radioactivity.
The cardiac output (CO) for each animal was determined by integrating the area underneath the first circulation-time curve as a function of time (see Fig. 1 ) and dividing this value into the administered dose of HSA-1251:
where C is the concentration of HSA-1251 in counts per minute at each time interval and tl and t2 are the times of appearance and projected disappearance of the pulse respectively. of the extraction ratio (ER) for antipyrineJ311 and the cardiac output. (Table  1) . Nevertheless, the levels of antipyrine-1311 in all brain areas appeared to remain constant from 60 to 90 set, indicating that the brain extraction rate was similar to that for the total body (37). In a similar manner, regional blood flows, as well as volumes, were obtained for animals convulsed for 5 min, but killed 60 set after the administration of antipyrine-1311.
Assay Procedures
Autoradiography. Autoradiograms of three frozen coronal brain sections l-Z-mm thick were prepared according to the methods previously reported from our laboratory (26). Determination of nonprotein-bound radioactivity. The percentage of nonprotein-bound radioactivity (also referred to as unbound or free radioactivity henceforth) in all tissues sampled was determined by precipitation of the protein-bound radioactivity with 8 % TCA. Plasma (0.01 ml) and CSF (1 ml) were mixed with 1 ml of 8 % TCA. Thalamus, cortex, and cerebellum (ZOO-400 mg), liver, muscle, nerve, and kidney (ZOO-400 mg) were mixed with 2 ml of 8 % TCA and homogenized.
After centrifugation at 5,000 rev/min for 10 min and filtration, aliquots of the clear supernatant were assayed for radioactivity.
The radioactivity in the supernatant was expressed as a percentage of the total activity in the liquid mixture for plasma and CSF, and in the homogenate for solid tissues. In contrast to plasma in which only a small percentage (0.7-2.4 %) of the radioactivity was free, an appreciable fraction of tissue activity (5.5-33.4 %) was found to be unbound.
To determine whether this amount of unbound activity could be identified as "free iodide" the original HSA-1251 solution, plasma (5-10 pl), CSF (0.5 ml), and buffer (0.1 M phosphate at pH 7.4) extracts of brain and peripheral tissues were subjected to gel-filtration on Sephadex G-25 (16 Tissue Uptake of HSA-12V
In the control nonconvulsed animals (group F) exposed to circulating HSA-1251 or HSA-1311 for 15 or 70 min, the greatest uptake occurred in the cerebral and cerebellar cortex, followed by nuclear subcortical areas and then myelinated areas (Table 2 ). There was no statistically significant difference in the brain uptake of HSA-1251 between control ani- The pattern of HSA-125I distribution was altered in convulsed animals. After 5 min of seizure HSA-1251 uptake into subcortical gray areas equaled or exceeded the uptake into cortical grey areas. Moreover, the levels established in all brain areas of convulsed animals were significantly higher than in comparable brain areas of the control animals. With increased duration of seizure activity the uptake of HSA-1251 was enhanced in all areas of brain but most markedly in the thalamus.
After 60 min a 24-fold increase was observed in thalamic levels.
Plasma radioactivity declined by approximately 10 % during the first 15 min of seizure activity and then leveled off, falling only l-2 % during the remainder of the experiment. No appreciable difference was noted in the plasma radioactivity between nonconvulsed and convulsed animals. With the exception of the thalamus, peripheral tissue uptake of HSA-1251 in convulsed and nonconvulsed animals was much greater than that observed in any of the brain areas assayed (Table  3) . However, unlike the uptake of HSA-1251 into thalamus, which continued to rise with seizure activity, the uptake in peripheral tissues leveled off by 15 min. Moreover, in contrast to the marked difference in the brain uptake of HSA-1251 by convulsed and nonconvulsed animals, the uptake of HSA-1251 in the peripheral tissues of the respective groups was quite similar.
The plasma volume and hematocrit prior to and during convulsions are presented in Table 4 , and little or no alteration was observed in these two parameters with the onset of, or during seizures. These results in paralyzed animals are different from the findings of Swingle et al. (44) who reported an immediate fall in the plasma volume and hemoconcentration in nonparalyzed dogs convulsed with pentylenetetrazol.
Nore$kephrine Infused-Convulsed Animals (Group Z)
The data on brain uptake of HSA-12!jI in animals infused with norepinephrine are presented in Table 5 . In nonconvulsed animals (group E), infusion of norepinephrine resulted in a modest overall increase in brain uptake of HSA-1251. (Table 7) .
Blood Flows
Blood flow to eight representative brain areas is presented in Table 1 . The values are somewhat lower than those reported by others (42) and could be the result of either a residual anesthetic effect and/or the paralysis induced by Flaxedil.
Nevertheless, convulsions of 5 min duration resulted in increased flow to all areas, but most markedly to medulla and subcortical areas (Table 8 ). In contrast, the greatest increase in blood volumes occurred in the cortical areas ( Table 9 ).
Metabolism of Radioiodinated Albumin
In nonconvulsed animals 1.1-2.4 % of the total radioactivity in plasma was unbound.
In peripheral tissues, the amount unbound ranged from 8.4-l 7.9 % while in brain However, in convulsed animals norepinephrine infusion resulted in marked increases in the uptake of HSA-1251 in subcortical nuclear areas, particularly in the thalamus. Treatment with methantheline appeared to suppress the uptake induced by convulsions even though the EEG indicated the presence of ongoing seizure activity during the 60-min period (Fig. 3) . The level of HSA-1251 in brain tissue at different time intervals after the arrest of seizure activity is presented in Table 6 . Within 5 min of seizure arrest the level in cerebral cortex, caudate nucleus, and hippocampus declined from the 60-min peak. Little or no decline occurred in white matter areas. The greatest decline in overall brain HSA-1251 activity occurred between 5-15 min. This fall was most apparent in the thalamus as illustrated in Fig. 4 . For most areas there was no further decline after 15 min even though the levels reached were still above control levels. However, with gel filtration, it was possible to fractionate the metabolites (Fig. 5) . Two radioactive peaks, with K, values of 0 and 0.8 were obtained for plasma, urine, muscle, and nerve. As indicated in bane/ A, the radioactive peak with a KD of 0.8 was presumably free reached. This rather marked regional difference in response to seizures suggested that in thalamus, unlike other areas of brain: a) the vasculature became progressively more permeable with ongoing seizure, b) the pool to which HSA-1251 had access became progressively larger, or c) metabolic breakdown or conversion of HSA-1251 was more extensive. Of the possibilities listed, we believe the evidence indicates that thalamic vasculature became progressively more permeable. Table 2 shows that after 5 min of seizure activity, HSA-1251 in thalamus increased some 200 % above control levels. During this same period the increase in cerebral cortex was only 30 % while that in white matter was 2 %. It could be argued that the greater amount of HSA-1251 accumulated in thalamus was not a reflection of altered vascular permeability, but due to greater vascular dilation and/or blood flow. Vasodilatation in cerebral blood vessels (38, 15) and increased blood flow (4 1) to brain in response to seizure activity have been well documented.
Nevertheless, in our given for convulsed animals in Table 2 using the Student t test or a modified t test (2). Significant difference was indicated when P < 0.05. -study the greatest increase in plasma volume occurred in cortical and not thalamic areas (Table 9 ). This observation is compatible with that of Cutler et al. (11) who reported that passage of HSA-1251 into brains of hypercapnic guinea pigs was greatest in areas which demonstrated the least vasodilatation.
Moreover, the percent increase in flow of blood to thalamus was less than that to cortex and to other brain areas which reflected limited elevations in HSA-1251 (Table 8) coefficients equal to or greater than 0.8, indicating that the molecular weight of these fractions was below 1,000 (Fig.  5) . One of these fractions had the same elution pattern as iodide -1251 (Fig. 5) in combination. However, even though large molecules are known to exchange freely between CSF and brain (6), the decline of HSA-1251 in CSF coincided with that of brain (Fig. 3) , making it' unlikely that a significant fraction of brain HSA-1251 diffused to CSF. Moreover, metabolic degradation of HSA-1251 combined with removal of the resulting by-products could only account for a certain proportion of the net reduction.
Therefore, it seems likely to us that a significant portion of the total HSA-1251 lost from brain was moved back to blood against a concentration gradient (19). It is unlikely that passage of HSA-1251 in either direction could be through *"tight junctions" (1, 7, 34, 39), since under more drastic experimental conditions passage of large molecules through these junctions has not been demonstrated (30). However, significant movement of large molecules between blood and brain has been shown to occur by pinocytosis under pathophysiological conditions (9, 31); and vesicular transit time across the endothelial cells is now thought to be brief (40). The fact that no new protein gains access to brain, minutes after seizure arrest, makes the movement of HSA-1251 by this process virtually unidirectional.
Obviously, the question of whether HSAlz51 enters and leaves brain by pinocytosis under pathophysiological conditions cannot be resolved without fine structure studies.
